2023-05-10 16:23:25 ET
- BioLife Solutions press release ( NASDAQ: BLFS ): Q1 GAAP EPS of -$0.32 misses by $0.11 .
- Revenue of $37.7M (+4.1% Y/Y) misses by $5.24M .
- We remain confident that we will achieve Q4 2024 run rate aspirational financial goals of $250 million in revenue, 50 points of adjusted gross margin and 30 points of adjusted EBITDA."
- Total revenue for 2023 is expected to range from $188 million to $202 million vs $192.7M consensus, reflecting year-over-year growth of 16% to 25%. Excluding COVID-19-related revenue, this range reflects year-over-year growth of 26% to 35%.
For further details see:
BioLife Solutions GAAP EPS of -$0.32 misses by $0.11, revenue of $37.7M misses by $5.24M